Barbiturates: their in vivo effects and potential biochemical mechanisms.
D000109:Acetylcholine / Q000378:metabolism; D000818:Animals; D000927:Anticonvulsants; D001463:Barbiturates / Q000494:pharmacology* / Q000627:therapeutic use; D001679:Biogenic Amines / Q000378:metabolism; D001921:Brain / Q000378:metabolism; D002118:Calcium / Q000378:metabolism; D002319:Cardiovascular System / Q000187:drug effects; D003292:Convulsants; D004305:Dose-Response Relationship, Drug; D004361:Drug Tolerance; D006801:Humans; D009424:Nervous System Physiological Phenomena; D018377:Neurotransmitter Agents / Q000378:metabolism; D010634:Phenobarbital / Q000494:pharmacology; D013329:Structure-Activity Relationship; D013569:Synapses / Q000502:physiology; D009435:Synaptic Transmission / Q000187:drug effects; D005680:gamma-Aminobutyric Acid / Q000502:physiology
D000927:Anticonvulsants; D001463:Barbiturates; D001679:Biogenic Amines; D003292:Convulsants; D018377:Neurotransmitter Agents; D005680:gamma-Aminobutyric Acid; D000109:Acetylcholine; D002118:Calcium; D010634:Phenobarbital